Organization
AbbVie Inc., Rheumatology, North Chicago, United States of America
1 abstract
Abstract
ACHIEVEMENT OF PARTIAL REMISSION AND INACTIVE DISEASE IN UPADACITINIB-TREATED PATIENTS WITH ANKYLOSING SPONDYLITISOrg: Oregon Health & Science University, Rheumatology, Portland, United States of America, Cabrini Hospital, Monash University & Emeritus Research, Melbourne, Australia, AbbVie Inc., Rheumatology, North Chicago, United States of America, AbbVie, Rheumatology, Baar, Switzerland, Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin, and Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany,